| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T288 |
0-24 |
Sentence |
denotes |
6.7 SARS-CoV-2-CNS risk |
| T289 |
25-162 |
Sentence |
denotes |
Mathew reported that it might be due to the obstructions in the nervous system, which may restrict the entry of air into the lungs [108]. |
| T290 |
163-227 |
Sentence |
denotes |
The virus enters the medullary neurons during the latency phase. |
| T291 |
228-413 |
Sentence |
denotes |
A possible mechanism explained was that the SARS-CoV-2 might enter the olfactory lobe of the brain through nasal chambers upon inhalation and may lead to inflammation and demyelination. |
| T292 |
414-503 |
Sentence |
denotes |
Later, it spreads to the whole brain due to its ability to cross the blood-brain barrier. |
| T293 |
504-640 |
Sentence |
denotes |
Some neurological symptoms exhibited by the COVID-19 infection patients include nausea, vomiting, and headache (represented in Table 1). |
| T294 |
641-855 |
Sentence |
denotes |
Since the SARS-CoV-2 possess the ability to cross the blood-brain barrier, it is important to design the drugs in such a way that they can cross the blood-brain barrier and scavenges the brain from viral infection. |
| T295 |
856-1063 |
Sentence |
denotes |
Also, it is essential to note that the respiratory illness accompanies neurological invasion by the virus, therapeutic care must be taken to prevent the viral entry into the central nervous system (CNS) [7]. |
